Strategic Leadership Shift Cohance Lifesciences Appoints Umang Vohra as Executive Chairman and Group CEO

Hyderabad: Cohance Lifesciences Limited, a leading technology-driven integrated CDMO platform, today announced a landmark leadership transition with the appointment of Umang Vohra as Executive Chairman and Group CEO. Mr. Vohra, the former CEO and Managing Director of Cipla Limited, is set to take the helm as Executive Chairman on May 1, 2026, followed by his transition into the Group CEO role on May 20, 2026.

A Visionary Leader for a High-Growth Platform:
The appointment is a calculated, strategic move by the Board to steer Cohance through its next phase of global expansion. Mr. Vohra succeeds Vivek Sharma, who is stepping down for personal reasons but will remain with the organization as an Advisor for the next nine months to facilitate a seamless transition.

With a career spanning over 30 years, Umang Vohra is recognized as one of the most influential figures in the Indian pharmaceutical sector. His decade-long tenure at Cipla was marked by a massive transformation into a diversified global enterprise, bringing an “owner-manager” mindset and a proven track record of operational excellence to the Cohance platform.

Strengthening the Science-Led Foundation:
Cohance Lifesciences has carved out a niche in the global CDMO (Contract Development and Manufacturing Organization) market through its specialization in.

• Complex Chemistry: Advanced multi-step synthesis and process R&D.
• Next-Gen Therapeutics: Expertise in ADCs (Antibody-Drug Conjugates) and oligonucleotides.
• Specialized Materials: High-performance API development and specialty ingredients.

The company is backed by integrated R&D centers and a powerhouse of over 400 scientists, positioning it as a critical partner for global pharmaceutical innovators.

Industry Perspectives:
“I believe deeply in the long-term value creation potential of this platform,” stated Umang Vohra. “Cohance’s technology offerings and R&D talent provide a strong foundation. I look forward to working with the management team to create value for customers and shareholders alike.”

Pankaj Patwari, Managing Director at Advent, expressed high confidence in the new appointment:
“The platform will greatly benefit from Umang’s global stature and operational depth. We are delighted to partner with him as we continue to drive commercial scale and deepen our customer partnerships.”

Legacy of Growth:
Outgoing Executive Chairman Vivek Sharma reflected on the platform’s journey, noting that the team has successfully established Cohance’s identity as a science-led leader. His tenure focused on integrating various business units and strengthening the leadership pipeline, leaving the platform well-positioned for the “next chapter” under Vohra’s guidance.